Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1986-08-27
1990-08-07
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Lymphokine
424 86, 424 88, 424 93, 435235, 435236, 435237, A61K 3912, C12N 704
Patent
active
049466763
ABSTRACT:
The invention relates to a new vaccine comprising a native protein capable of inducing the production of protective antibodies in a host, together with an adjuvant amount of certain proteins or peptides which, as such, are not capable of inducing substantial protective antibody titres but considerably enhance the immunizing activity of said native protein.
The amino acid sequences of the adjuvant proteins and peptides show homology with the native proteins. Combination of inactivated picornavirus, such as poliovirus, with adjuvant amounts of denatured picornavirus, such as poliovirus, capsis proteins, in a vaccine, is highly advantageous.
REFERENCES:
Van Wezel et al., "New Approach to the Production of Concentrated and Purified Inactivated Polio and Rabies Tissue Culture Vaccines", 15th. IABS Congress, Develop. Biol. Standard, vol. 41, pp. 159-168, (S. Karger, Basel, 1978).
Van Wezel et al., "Inactivated Poliovirus Vaccine: Current Production Methods and New Developments", Reviews of Infectious Diseases, vol. 6, supplement 2, pp. S335-S340, 1984.
Embo J., 4, (1985), pp. 3339-3343.
Dev. Biol. Stand., 55, (1984), pp. 209-215.
Nature, 304, (1983), pp. 699-703.
Science, 229, (1985), pp. 1358-1365.
Nature, 291 (1981), pp. 547-553.
J. Mol. Biol., 174, (1984), pp. 561-585.
Proc. Natl. Acad. Sci. U.S.A., 81, (1984), pp. 1539-1543.
Proc. Natl. Acad. Sci. U.S.A., 82, (1985), pp. 2627-2631.
Nucl. Ac. Res., 13, (1985), pp. 2111-2125.
Proc. Natl. Acad. Sci. U.S.A., 82, (1985), pp. 732-736.
Vir. Res., 3, (1985), pp. 263-270.
Nucl. Ac. Res., 12, (1984), pp. 2969-2985.
Gene, 17, (1982), pp. 153-161.
Nucl. Ac. Res., 12, (1984), pp. 6587-6601.
Virology, 140, (1985), pp. 13-20.
Nature, 301, (1983), pp. 674-679.
J. Virol., 57, (1986), pp. 246-257.
Develop. Biol. Stand, 41, (1978), pp. 159-168.
Rev. Inf. Dis., 6, (1984), pp. 335-340.
Anal. Biochem., 83, pp. 346-356, (1977).
Virology, 130, pp. 243-246, (1983).
Nature, 227, pp. 680-685, (1970).
Proc. Natl. Acad. Sci. U.S.A., 76, pp. 4350-4354, (1979).
Vaccine, 1, pp. 17-22, (1983).
Beuvery Eduard C.
Hazendonk Antonius G.
Van Wezel Antonius L.
De Staat Der Nederlanden
Mohamed Abdel A.
Moskowitz Margaret
LandOfFree
Vaccine comprising an immunogenic protein and, as an adjuvant, a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine comprising an immunogenic protein and, as an adjuvant, a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine comprising an immunogenic protein and, as an adjuvant, a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-959730